Relationship between TSH levels in the normal range and short-term duloxetine efficacy

Journal of Affective Disorders

Volumn 123, Issue 1-3, 2010, Pages 312-316

  Corruble, Emmanuelle ^a   Goldberger, Celine ^b   Spann, Melissa ^b  

^a Universite Paris Sud   (France)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Antidepressants; Duloxetine; Efficacy; Major depression; Placebo; TSH levels

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; DULOXETINE; HYPNOTIC AGENT; PLACEBO; THYROTROPIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; POST HOC ANALYSIS; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SHORT COURSE THERAPY; THYROTROPIN BLOOD LEVEL;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; PERSONALITY INVENTORY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS; THIOPHENES; THYROTROPIN; TREATMENT OUTCOME;

EID: 77952322491     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2009.09.012     Document Type: Article

References (35)

1. Altshuler L.L., Bauer M., Frye M.A., Gitlin M.J., Mintz J., Szuba M.P., Leight K.L., and Whybrow P.C. Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. Am. J. Psychiatry 158 (2001) 1617-1622
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition (1994), American Psychiatric Association, Washington DC
3. Berlin I., and Corruble E. Thyroid hormones and antidepressant response. Am. J. Psychiatry 159 (2002) 1441
4. Berlin I., Payan C., Corruble E., and Puech A.J. Serum thyroid-stimulating-hormone concentration as an index of severity of major depression. Int. J. Neuropsychopharmacol. 2 (1999) 105-110
5. Biondi B., and Cooper D.S. The clinical significance of subclinical thyroid dysfunction. Endocr. Rev. 29 (2008) 76-131
6. Brannan S.K., Mallinckrodt C.H., Brown E.B., Wohlreich M.M., Watkin J.G., and Schatzberg A.F. Duloxetine 60 mg once daily in the acute treatment of patients with major depression and painful physical symptoms. J. Psychiatr. Res. 39 (2005) 43-53
7. Brouwer J.P., Appelhof B.C., Peeters R.P., Hoogendijk W.J., Huyser J., Schene A.H., Tijssen J.G., Van Dyck R., Visser T.J., Wiersinga W.M., and Fliers E. Thyrotropin, but not a polymorphism in type II deiodinase, predicts response to paroxetine in major depression. Eur. J. Endocrinol. 154 (2006) 819-825
8. Corruble E., Berlin I., Lemoine A., and Hardy P. Should major depression with 'high normal' thyroid-stimulating hormone be treated preferentially with tricyclics?. Neuropsychobiology 50 (2004) 144-146
9. Detke M.J., Lu Y., Goldstein D.J., Hayes J.R., and Demitrack M.A. Duloxetine 60 mg once daily for major depressive disorder: a randomized double-blind placebo-controlled trial. J. Clin. Psychiatry 63 (2002) 308-315
10. Detke M.J., Lu Y., Goldstein D.J., McNamara R.K., and Demitrack M.A. Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression. J. Psychiatr. Res. 36 (2002) 383-390
11. Detke M.J., Wiltse C.G., Mallinckrodt C.H., McNamara R.K., Demitrack M.A., and Bitter I. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Eur. Neuropsychopharmacol. 14 (2004) 457-470
12. Duval F., Mokrani M.C., Crocq M.A., Jautz M., Bailey P., Diep T.S., and Macher J.P. Effect of antidepressant medication on morning and evening thyroid function tests during a major depressive episode. Arch. Gen. Psychiatry 53 (1996) 833-840
13. Eker S.S., Akkaya C., Sarandol A., Cangur S., Sarandol E., and Kirli S. Effects of various antidepressants on serum thyroid hormone levels in patients with major depressive disorder. Prog. Neuro-psychopharmacol. Biol. Psychiatry 32 (2008) 955-961
14. Fava M., Labbate L.A., Abraham M.E., and Rosenbaum J.F. Hypothyroidism and hyperthyroidism in major depression revisited. J. Clin. Psychiatry 56 (1995) 186-192
15. Gitlin M., Altshuler L.L., Frye M.A., Suri R., Huynh E.L., Fairbanks L., Bauer M., and Korenman S. Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors. J. Psychiatry Neurosci. 29 (2004) 383-386
16. Gold M.S., Pottash A.L., and Extein I. Hypothyroidism and depression. Evidence from complete thyroid function evaluation. JAMA 245 (1981) 1919-1922
17. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
18. Hansen P.S., Brix T.H., Iachine I., Sørensen T.I., Kyvik K.O., and Hegedüs L. Genetic and environmental interrelations between measurements of thyroid function in a healthy Danish twin population. Am. J. Physiol., Endocrinol. Metabol. 292 (2007) E765-E770
19. Hollowell J.G., Staehling N.W., Flanders W.D., Hannon W.H., Gunter E.W., Spencer C.A., and Braverman L.E. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87 (2002) 489-499
20. Howland R.H. Thyroid dysfunction in refractory depression: implication for pathophysiology and treatment. J. Clin. Psychiatry 54 (1993) 47-54
21. Joffe R.T., and Levitt A.J. Major depression and subclinical (grade 2) hypothyroidism. Psychoneuroendocrinology 17 (1992) 215-221
22. Joffe R.T. The thyroid and depression. In: Joffe R.T., and Levitt A.J. (Eds). The Thyroid Axis and Psychiatric Illness (1993), American Psychiatric Press, Washington DC 265-290
23. Joffe R.T. Peripheral thyroid hormone levels in treatment resistant depression. Biol. Psychiatry 45 (1999) 1053-1055
24. Joffe R.T., and Levitt A.J. Basal thyrotropin and major depression: relation to clinical variables and treatment outcome. Can. J. Psychiatry 53 12 (2008) 833-838
25. Kirkegaard C., and Faber J. The role of thyroid hormones in depression. Eur. J. Endocrinol. 138 (1998) 1-9
26. Nemeroff C.B. Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal. J. Clin. Psychiatry 50 (1989) 13-20
27. Nierenberg A.A., Greist J.H., Mallinckrodt C.H., Prakash A., Sambunaris A., Tollefson G.D., and Wohlreich M.M. Duloxetine versus escitalopram and placebo in the treatment of patients with MDD: onset of antidepressant action, a non-inferiority study. Curr. Med. Res. Opin. 23 (2007) 401-416
28. Perahia D.G., Wang F., Mallinckrodt C.H., Walker D.J., and Detke M.J. Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Eur. Psychiatr. 21 (2006) 367-378
29. Prange Jr. A.J. Novel uses of thyroid hormones in patients with affective disorders. Thyroid 5 (1996) 537-543
30. Raskin J., Wiltse C.G., Siegal A., Sheikh J., Xu J., Dinkel J.J., Rotz B.T., and Mohs R.C. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. Am. J. Psychiatry 164 (2007) 900-909
31. Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., Warden D., Niederehe G., Thase M.E., Lavori P.W., Lebowitz B.D., McGrath P.J., Rosenbaum J.F., Sackeim H.A., Kupfer D.J., Luther J., and Fava M. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry 163 (2006) 1905-1917
32. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., and Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59 (1998) 22-33
33. Sullivan P.F., Wilson D.A., Mulder R.T., and Joyce P.R. The hypothalamic-pituitary-thyroid axis in major depression. Acta Psychiatr. Scand. 95 (1997) 370-378
34. Surks M.I., Ortiz E., Daniels G.H., Sawin C.T., Col N.F., Cobin R.H., Franklyn J.A., Hershman J.M., Burman K.D., Denke M.A., Gorman C., Cooper R.S., and Weissman N.J. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291 (2004) 228-238
35. Vandoolaeghe E., Maes M., Vandevyvere J., and Neels H. Hypothalamic-pituitary-thyroid-axis function in treatment resistant depression. J. Affect. Disord. 43 (1997) 143-150